Trial intelligence / Profile preview

Botulinum toxin for idiopathic rhinitis

RBR-4jbw4sCompleted

Sponsor
Universidade de São Paulo
Start
May 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of botulinum toxin type A in Perennial Nonallergic Rhinitis (NAR) (2 arms), sponsored by Universidade de São Paulo. Started May 2018; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Perennial Nonallergic Rhinitis (NAR)

Beyond the preview

Go deeper on RBR-4jbw4s.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4jbw4s.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call